mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |